|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-OST
, in Cholestasis in Humans and Rodents
1 Liver Center, Yale University School of Medicine, New Haven, CT, USA
2 Division of Gastroenterology and Hepatology, Department of Medicine, Medical University, Graz, Austria
3 Department of Environmental Medicine, University of Rochester School of Medicine, Rochester, NY, USA
* To whom correspondence should be addressed. E-mail: james.boyer{at}yale.edu.
OST
-OST
is a novel heterodimeric bile acid and sterol transporter expressed at the basolateral membranes of epithelium in the ileum, kidney and liver. To determine if OST
-OST
undergoes FXR dependent adaptive regulation following cholestatic liver injury, mRNA and protein expression levels were analyzed in patients with primary biliary cirrhosis (PBC) and following common bile duct ligation (CBDL) in rats and Fxr null and wild type mice. Hepatic OST
and OST
mRNA increased 3 and 32 fold respectively in patients with PBC compared to controls while expression of Ost
and Ost
also increased in the liver of rats and mice following CBDL. In contrast, expression of OST
and OST
mRNA was generally lower in Fxr null mice whereas CBDL failed to enhance expression of OST
and OST
when compared to wild type mice. HepG2 cells treated for 24 hours with chenodeoxycholic acid, a selective FXR ligand, had higher levels of OST
and OST
mRNA and protein. Increases in OST protein were visualized by confocal microscopy at the plasma membrane. These results indicate that expression of Ost
and Ost
are highly regulated in response to cholestatic liver injury and that this response is dependent on the FXR bile acid receptor.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |